ArticleJournal of hepatocellular carcinoma2026

TACE Combined with Targeted Immunotherapy: A Strategy for Liver Transplantation Conversion and Survival Benefits in Patients with BCLC Stage B/C HCC.

Hanyuan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.